This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Healthcare Provider Remove Networking Remove Pharmaceutical manufacturing Related Topics
Pharma Rep Pharma reps Prescription Specialization Food and Drug Administration Healthcare Pharma Physicians Patients FDA More Related Topics >
article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

OCTOBER 26, 2021

With the myriad of guidance and recommendations to boost diversity and inclusion in oncology trials, , biotech and pharmaceutical manufacturers are left to interpret the criteria and implement them through tangible action. J National Comprehensive Cancer Network. 2019;17(11):1309-1316. doi:10.6004/jnccn.2019.7321

Food and Drug Administration 52
Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52
article thumbnail

Trends in Virtual Collaboration

Impetus Digital

NOVEMBER 23, 2023

In these online programs, a handful of carefully selected KOLs attending the congress are asked to summarize abstracts that will be of special interest to other healthcare providers from their country/region or specialty. Some want to attend live meetings (whether web-based, hybrid, or in person) to be able to network “face-to-face.”

Education 52
Education Healthcare Provider Physicians Pharma 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024